Skip to main content
Download PDF

Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal

Annals of General Psychiatry volume 20, Article number: 52 (2021) Cite this article

Abstract

Background

Patients suffering from severe mental disorders, including schizophrenia, major depression and bipolar disorders, have a reduced life expectancy compared to the general population of up to 10–25 years. This mortality gap requires urgent actions from a public health perspective in order to be reduced.

Main text

Factors associated with the high mortality rates in patients with severe mental disorders can be grouped into four groups: those related to the patients, to psychiatrists, to other non-psychiatrist medical doctors and to the healthcare system. Each of these factors should become the target of specific and dedicated interventions, in order to reduce the morbidity and mortality rate in patients with severe mental disorders. All these elements contribute to the neglect of physical comorbidity in patients with severe mental. In particular, the long-standing separation of psychiatry from other branches of medicine and the lack of specific training on this issue further contribute to the poor attention dedicated to management of physical comorbidities. Recently, several professional associations have invited national bodies regulating education of healthcare professionals to include the management of physical health of people with severe mental disorders in undergraduate and postgraduate educational programs.

Conclusions

The premature mortality in patients with severe mental disorders is a complex phenomenon resulting by the interaction of several protective and risk factors. Therefore, a multilevel approach is needed, in which the different stakeholders involved in health care provision establish workforces for the long-term management of physical and mental health conditions.

Background

Patients suffering from severe mental disorders, such as schizophrenia, major depression and bipolar disorders, have a reduced life expectancy compared to the general population of up to 10–25 years [1, 2]. This “mortality gap” between the general population and patients with severe mental disorders has been rightly described as a “public health scandal” [3, 4], requiring urgent actions from healthcare professionals and governments worldwide. Life expectancy is substantially grown in high-income countries, due to medical advancements, improvements in hygiene and food supply, but it remains unacceptably low in lesser income countries [5,6,7,8].

Main text

This high mortality rate is not due to mental illness per se, rather it is the consequence of the simultaneous presence of comorbid physical health problems, such as cardiovascular, respiratory, metabolic, infectious diseases and cancer [9,10,11,12]. In addition, people with severe mental disorders are at higher risk of developing obesity and metabolic syndrome than the general population—with a prevalence rate of these conditions ranging from 40 to 70% in patients with schizophrenia and 20–30% in persons with bipolar disorders [13,14,15,16,17,18].

Factors associated with the high mortality rates in patients with severe mental disorders can be grouped into four groups: those related to the patients, to psychiatrists, to other non-psychiatrist medical doctors and to the healthcare system [19]. Factors related to patients include some of the characteristics of mental disorders such as the decline in cognitive functioning [20, 21], the patient’s reluctance to attend check-up visits [22,23,24,25,26], the neglect of physical health needs by patients and their caregivers [27], and the adoption of unhealthy lifestyle behavior [28,29,30,31], including heavy smoking [32,33,34], unbalanced diet [35], and substance abuse [36,37,38,39]. Another factor contributing to the higher mortality rate in this patient group is the intake of some antipsychotic and antidepressant medications which have metabolic side effects [40,41,42,43,44,45,46,47,48,49,50,51]. Psychiatrists frequently focus on mental rather than on physical health of their patients, rarely undertake physical examinations and often have poor communication and collaboration with primary care physicians or other clinicians, partly due to the long-standing separation of psychiatric departments from other medical wards or hospitals [52,53,54,55]. Conversely, non-psychiatric clinicians frequently have a negative attitude towards people with mental disorders, underestimating the seriousness of their complaints of signs of physical illness [56,57,58]. Healthcare-related factors also hamper care for physical health of patients with severe mental disorders: there is often no clarity about the person or the team who are responsible for detecting and managing physical problems in patients with severe mental disorders and the lack of access to health care services for patients with severe mental disorders is hampered [59, 60]. The excessive division and over-specialization of medical disciplines and the fragmentation of medical knowledge [61,62,63] also play an important role: some psychiatrists only deal with specific age groups (e.g., adolescents or the elderly) or specific diseases (e.g., only with eating disorders) or stages in disease-development (e.g., early intervention services) [64].

The neglect of physical comorbidity in patients with severe mental disorders is in part due to long-standing separation of psychiatry from other branches of medicine and also to the lack of attention to comorbidity during the undergraduate and postgraduate training of psychiatrists and other medical specialists [65,66,67,68]. For a long time, the prevalence of comorbidity has been underestimated by health care professionals and—on the other hand—patients have been reluctant to speak to psychiatrists about their physical health problems. Recently, professional associations such as the Royal College of Psychiatrists, the Royal College of Practitioners, the European Psychiatric Association (EPA) and the World Psychiatric Association (WPA) as well as the World Health Organization (WHO) invited national bodies regulating education of healthcare professionals to include the management of physical health of people with severe mental disorders in undergraduate and postgraduate educational programs [69,70,71]. A revision of educational requirements for healthcare professionals to improve their training curricula has also been proposed in order to adequately prepare the young generation of professionals to manage physical comorbidities in patients with severe mental disorders. In particular, the WPA, the world’s largest professional association of psychiatrists and mental health professionals [72, 73], has recently established a WPA Working Group on Physical Comorbidities [74, 75], so to promote attention to management of physical comorbidities in people with severe mental disorders, to update training materials available on the educational portal of the Association [76], to organize webinars and seminars with international experts in the field [77,78,79] and to promote the dissemination of good clinical practice for improving physical health in patients with severe mental disorders [80,81,82,83].

Conclusion

The WHO has recently developed international guidelines on how to improve physical health in people with severe mental disorders [84]. According to the WHO, the premature mortality is a complex phenomenon resulting by the interaction of several protective and risk factors; therefore, a multilevel approach is needed, in which the different stakeholders involved in health care provision establish workforces for the long-term management of physical and mental health conditions [85,86,87]. The different stakeholders would include policy-makers, psychiatrists, other medical specialists, users, and carers of people with mental disorders [88]. The actions to be implemented include control of risk factors, scaling up management in primary health care, and development of national policies. At the level of scaling up management of primary health care, the education of clinicians, general practitioners and early career psychiatrists represent an essential element to really challenge the “scandal of premature mortality” in people with mental disorders [89, 90].

Availability of data and materials

Not applicable.

Abbreviations

WHO:

World Health Organization

WPA:

World Psychiatric Association

EPA:

European Psychiatric Association

References

  1. Plana-Ripoll O, Musliner KL, Dalsgaard S, et al. Nature and prevalence of combinations of mental disorders and their association with excess mortality in a population-based cohort study. World Psychiatry. 2020;19(3):339–49.

    PubMed Central  PubMed  Google Scholar 

  2. De Rosa C, Sampogna G, Luciano M, et al. Improving physical health of patients with severe mental disorders: a critical review of lifestyle psychosocial interventions. Expert Rev Neurother. 2017;17:667–81.

    PubMed  Google Scholar 

  3. Thornicroft G. Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry. 2011;199(6):441–2. https://doi.org/10.1192/bjp.bp.111.092718.

    Article  PubMed  Google Scholar 

  4. Fiorillo A, Luciano M, Pompili M, Sartorius N. Editorial: Reducing the mortality gap in people with severe mental disorders: the role of lifestyle psychosocial interventions. Front Psychiatry. 2019;10:434.

    PubMed Central  PubMed  Google Scholar 

  5. Crimmins EM. Lifespan and healthspan: past, present, and promise. Gerontologist. 2015;55(6):901–11. https://doi.org/10.1093/geront/gnv130 (Epub 2015 Nov 10).

    Article  PubMed Central  PubMed  Google Scholar 

  6. Unützer J, Carlo AD, Collins PY. Leveraging collaborative care to improve access to mental health care on a global scale. World Psychiatry. 2020;19(1):36–7.

    PubMed Central  PubMed  Google Scholar 

  7. Gross JJ, Uusberg H, Uusberg A. Mental illness and well-being: an affect regulation perspective. World Psychiatry. 2019;18(2):130–9.

    PubMed Central  PubMed  Google Scholar 

  8. Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015;72:1172–81.

    PubMed  Google Scholar 

  9. Nielsen RE, Banner J, Jensen SE. Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol. 2021;18(2):136–45.

    PubMed  Google Scholar 

  10. Palmer VJ, Lewis M, Stylianopolous V, Furler J. Primary care prevention of the cardiovascular health crisis for people with severe mental illnesses: the elephant in the room. Aust J Gen Pract. 2018;47(12):846–50. https://doi.org/10.31128/AJGP-09-18-4692.

    Article  PubMed  Google Scholar 

  11. Eisenberger NI, Moieni M. Inflammation affects social experience: implications for mental health. World Psychiatry. 2020;19(1):109-110. 

    PubMed Central  PubMed  Google Scholar 

  12. Wysokinski A, Strzelecki D, Kloszewska I. Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder. Diabetes Metab Syndr. 2015;9:168–76.

    PubMed  Google Scholar 

  13. Dalkner N, Bengesser SA, Birner A, Fellendorf FT, Fleischmann E, Großschädl K, Lenger M, Maget A, Platzer M, Queissner R, Schönthaler E, Tmava-Berisha A, Reininghaus EZ. Metabolic syndrome impairs executive function in bipolar disorder. Front Neurosci. 2021;15: 717824. https://doi.org/10.3389/fnins.2021.717824.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Filipčić I, ŠimunovićFilipčić I, Grošić V, Bakija I, Šago D, Benjak T, Uglešić B, Bajić Ž, Sartorius N. Patterns of chronic physical multimorbidity in psychiatric and general population. J Psychosom Res. 2018;114:72–80. https://doi.org/10.1016/j.jpsychores.2018.09.011 (Epub 2018 Sep 25).

    Article  PubMed  Google Scholar 

  15. Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301. https://doi.org/10.1016/S2215-0366(17)30078-0.

    Article  PubMed  Google Scholar 

  16. Uju Y, Kanzaki T, Yamasaki Y, Kondo T, Nanasawa H, Takeuchi Y, Yanagisawa Y, Kusanishi S, Nakano C, Enomoto T, Sako A, Yanai H, Mishima S, Mimori S, Igarashi K, Takizawa T, Hayakawa T. A cross-sectional study on metabolic similarities and differences between inpatients with schizophrenia and those with mood disorders. Ann Gen Psychiatry. 2020;19:53. https://doi.org/10.1186/s12991-020-00303-5.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013;170:324–33.

    PubMed  Google Scholar 

  18. Smith DJ, Langan J, McLean G, Guthrie B, Mercer SW. Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study. BMJ Open. 2013;3: e2808.

    Google Scholar 

  19. Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand. 2007;116(5):317–33.

    CAS  PubMed  Google Scholar 

  20. Menon V. Brain networks and cognitive impairment in psychiatric disorders. World Psychiatry. 2020;19(3):309–10.

    PubMed Central  PubMed  Google Scholar 

  21. Moritz S, Silverstein SM, Dietrichkeit M, Gallinat J. Neurocognitive deficits in schizophrenia are likely to be less severe and less related to the disorder than previously thought. World Psychiatry. 2020;19(2):254–5.

    PubMed Central  PubMed  Google Scholar 

  22. De Leon J, Sanz EJ, Norén GN, De Las CC. Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics. World Psychiatry. 2020;19(1):120–1.

    PubMed Central  PubMed  Google Scholar 

  23. Kisely S, Crowe E, Lawrence D. Cancer-related mortality in people with mental illness. JAMA Psychiatry. 2013;70(2):209–17.

    PubMed  Google Scholar 

  24. Ronaldson A, Elton L, Jayakumar S, Jieman A, Halvorsrud K, Bhui K. Severe mental illness and health service utilisation for nonpsychiatric medical disorders: a systematic review and meta-analysis. PLoS Med. 2020;17(9): e1003284.

    PubMed Central  PubMed  Google Scholar 

  25. Heiberg IH, Nesvåg R, Balteskard L, Bramness JG, Hultman CM, Naess Ø, et al. Diagnostic tests and treatment procedures performed prior to cardiovascular death in individuals with severe mental illness. Acta Psychiatr Scand. 2020;141(5):439–51.

    CAS  PubMed Central  PubMed  Google Scholar 

  26. Miller AH. Beyond depression: the expanding role of inflammation in psychiatric disorders. World Psychiatry. 2020;19(1):108-109. 

    PubMed Central  PubMed  Google Scholar 

  27. Cohen MAA, Makurumidze G, Pereira LF, Bourgeois JA, Cozza KL. HIV/AIDS psychiatry—a paradigm for HIV prevention and integrated compassionate care. World Psychiatry. 2019;18(2):240–1.

    PubMed Central  PubMed  Google Scholar 

  28. Luciano M, Sampogna G, Del Vecchio V, Giallonardo V, Palummo C, Andriola I, Amore M, Rossi R, Carmassi C, Siracusano A, Fiorillo A, LIFESTYLE Working Group. The impact of clinical and social factors on the physical health of people with severe mental illness: results from an Italian multicentre study. Psychiatry Res. 2021;303: 114073.

    PubMed  Google Scholar 

  29. Firth J, Teasdale SB, Allott K, et al. The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry. 2019;18(3):308–24.

    PubMed Central  PubMed  Google Scholar 

  30. Dinan TG, Cryan JF. Gut microbiota: a missing link in psychiatry. World Psychiatry. 2020;19(1):111-112. 

    PubMed Central  PubMed  Google Scholar 

  31. Ekelund U, Steene-Johannessen J, Brown WJ, et al. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet. 2016;388:1302–10.

    PubMed  Google Scholar 

  32. Chesney E, Robson D, Patel R, Shetty H, Richardson S, Chang CK, McGuire P, McNeill A. The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: an electronic case register cohort study. Schizophr Res. 2021;238:29–35.

    PubMed  PubMed Central  Google Scholar 

  33. Di Forti M. To legalize or not to legalize cannabis, that is the question! World Psychiatry. 2020 ;19(2):188-189.

    Google Scholar 

  34. Ringin E, Cropley V, Zalesky A, Bruggemann J, Sundram S, Weickert CS, Weickert TW, Bousman CA, Pantelis C, Van Rheenen TE. The impact of smoking status on cognition and brain morphology in schizophrenia spectrum disorders. Psychol Med. 2021. https://doi.org/10.1017/S0033291720005152.

    Article  PubMed  Google Scholar 

  35. Heald A, Pendlebury J, Anderson S, Narayan V, Guy M, Gibson M, Haddad P, Livingston M. Lifestyle factors and the metabolic syndrome in schizophrenia: a cross-sectional study. Ann Gen Psychiatry. 2017;16:12.

    PubMed Central  PubMed  Google Scholar 

  36. Volkow ND, Torrens M, Poznyak V, et al. Managing dual disorders: a statement by the informal scientific network, UN Commission on narcotic drugs. World Psychiatry. 2020;19(3):396–7.

    PubMed Central  PubMed  Google Scholar 

  37. Squeglia LM. Alcohol and the developing adolescent brain. World Psychiatry. 2020;19(3):393–4.

    PubMed Central  PubMed  Google Scholar 

  38. Drake RE, Xie H, McHugo GJ. A 16-year follow-up of patients with serious mental illness and co-occurring substance use disorder. World Psychiatry. 2020;19(3):397–8.

    PubMed Central  PubMed  Google Scholar 

  39. Firth J, Solmi M, Wootton RE, et al. A meta-review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders. World Psychiatry. 2020;19(3):360–80.

    PubMed Central  PubMed  Google Scholar 

  40. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2012;8(2):114–26.

    Google Scholar 

  41. Taipale H, Tanskanen A, Mehtӓlӓ J, Vattulainen P, Correll CU, Tiihonen J. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry. 2020;19(1):61–8.

    PubMed Central  PubMed  Google Scholar 

  42. Wen FK, Crosby K, Miller BH, Rommen M, Kirzner SJ, Hoberecht T, Migdalski A. Association of first-line antidepressants and incident adverse metabolic effects. Can Fam Physician. 2020;66(12):898–900.

    PubMed Central  PubMed  Google Scholar 

  43. Correll CU, Sikich L, Reeves G, et al. Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial. World Psychiatry. 2020;19(1):69–80.

    PubMed Central  PubMed  Google Scholar 

  44. Solmi M, Fornaro M, Ostinelli EG, et al. Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of adverse effects. World Psychiatry. 2020;19(2):214–32.

    PubMed Central  PubMed  Google Scholar 

  45. Kishimoto T, Hagi K, Nitta M, Kane JM, Correll CU. Long-term effectiveness of oral second-generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta-analysis of direct head-to-head comparisons. World Psychiatry. 2019;18(2):208–24.

    PubMed Central  PubMed  Google Scholar 

  46. Boschloo L, Bekhuis E, Weitz ES, et al. The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis. World Psychiatry. 2019;18(2):183–91.

    PubMed Central  PubMed  Google Scholar 

  47. Postolache TT, Del Bosque-Plata L, Jabbour S, Vergare M, Wu R, Gragnoli C. Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome. Am J Med Genet B Neuropsychiatr Genet. 2019;180(3):186–203.

    CAS  PubMed Central  PubMed  Google Scholar 

  48. Freyberg Z, Aslanoglou D, Shah R, Ballon JS. Intrinsic and antipsychotic drug-induced metabolic dysfunction in schizophrenia. Front Neurosci. 2017;11:432.

    PubMed Central  PubMed  Google Scholar 

  49. Howell S, Yarovova E, Khwanda A, Rosen SD. Cardiovascular effects of psychotic illnesses and antipsychotic therapy. Heart. 2019;105(24):1852–9.

    CAS  PubMed  Google Scholar 

  50. Miron IC, Baroană VC, Popescu F, Ionică F. Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders. Curr Health Sci J. 2014;40(1):12–7.

    PubMed  Google Scholar 

  51. Mathews J, Newcomer JW, Mathews JR, Fales CL, Pierce KJ, Akers BK, et al. Neural correlates of weight gain with olanzapine. Arch Gen Psychiatry. 2012;69(12):1226–37.

    CAS  PubMed  Google Scholar 

  52. Chew-Graham CA, Gilbody S, Curtis J, Holt RI, Taylor AK, Shiers D. Still ‘being bothered about Billy’: managing the physical health of people with severe mental illness. Br J Gen Pract. 2021;71(709):373–6.

    PubMed  Google Scholar 

  53. Lerbæk B, Jørgensen R, Aagaard J, Nordgaard J, Buus N. Mental health care professionals’ accounts of actions and responsibilities related to managing physical health among people with severe mental illness. Arch Psychiatr Nurs. 2019;33(2):174–81.

    PubMed  Google Scholar 

  54. Reilly S, Planner C, Gask L, Hann M, Knowles S, Druss B, Lester H. Collaborative care approaches for people with severe mental illness. Cochrane Database Syst Rev. 2013;11:CD009531.

    Google Scholar 

  55. McBain H, Lamontagne-Godwin F, Haddad M, Simpson A, Chapman J, Jones J, Flood C, Mulligan K. Management of type 2 diabetes mellitus in people with severe mental illness: an online cross-sectional survey of healthcare professionals. BMJ Open. 2018;8(2): e019400.

    PubMed Central  PubMed  Google Scholar 

  56. Robson D, Haddad M, Gray R, Gournay K. Mental health nursing and physical health care: a cross-sectional study of nurse’ attitudes, practice, and perceived training needs for the physical health care of people with severe mental illness. Int J Ment Health Nurs. 2013;22(5):409–17.

    PubMed  Google Scholar 

  57. Stanton R, Reaburn P, Happell B. Barriers to exercise prescription and participation in people with mental illness: the perspectives of nurses working in mental health. J Psychiatr Ment Health Nurs. 2015;22(6):440–8.

    CAS  PubMed  Google Scholar 

  58. Sherwood DA. Healthcare curriculum influences on stigma towards mental illness: core psychiatry course impact on pharmacy, nursing and social work student attitudes. Curr Pharm Teach Learn. 2019;11(2):198–203.

    PubMed  Google Scholar 

  59. BjörkBrämberg E, Torgerson J, Norman Kjellström A, Welin P, Rusner M. Access to primary and specialized somatic health care for persons with severe mental illness: a qualitative study of perceived barriers and facilitators in Swedish health care. BMC Fam Pract. 2018;19(1):12.

    Google Scholar 

  60. Lawrence D, Kisely S. Inequalities in healthcare provision for people with severe mental illness. J Psychopharmacol. 2010;24(4 Suppl):61–8.

    PubMed Central  PubMed  Google Scholar 

  61. Lloyd HM, Pearson M, Sheaff R, Asthana S, Wheat H, Sugavanam TP, Britten N, Valderas J, Bainbridge M, Witts L, Westlake D, Horrell J, Byng R. Collaborative action for person-centred coordinated care (P3C): an approach to support the development of a comprehensive system-wide solution to fragmented care. Health Res Policy Syst. 2017;15(1):98.

    PubMed Central  PubMed  Google Scholar 

  62. Fan D. Holistic integrative medicine: toward a new era of medical advancement. Front Med. 2017;11:152–9.

    PubMed  Google Scholar 

  63. Baker M, Wessely S, Openshaw D. Not such friendly banter? GPs and psychiatrists against the systematic denigration of their specialties. Br J Gen Pract. 2016. https://doi.org/10.3399/bjgp16X687169.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Stein DJ, Betancourt OA, Emsley RA, Jeenah Y, Mkize D, Pretorius J, Rataemane S, Roos L, Szabo CP. Sub-specialties in psychiatry: towards parity in mental health training and services. S Afr Med J. 2009;99(1):38–9.

    PubMed  Google Scholar 

  65. De Rosa C, Sampogna G, Luciano M, Del Vecchio V, Fabrazzo M, Fiorillo A. Social versus biological psychiatry: it’s time for integration! Int J Soc Psychiatry. 2018;64(7):617–21. https://doi.org/10.1177/0020764017752969 (Epub 2018 Apr 12).

    Article  PubMed  Google Scholar 

  66. Glew S, Chapman B. Closing the gap between physical and mental health training. Br J Gen Pract. 2016;66(651):506–7.

    PubMed Central  PubMed  Google Scholar 

  67. Pereira L, Budovich A, Claudio-Saez M. Monitoring of metabolic adverse effects associated with atypical antipsychotics use in an outpatient psychiatric clinic. J Pharm Pract. 2019;32(4):388–93.

    PubMed  Google Scholar 

  68. Morrato EH, Campagna EJ, Brewer SE, Dickinson LM, Thomas DS, Miller BF, et al. Metabolic testing for adults in a state medicaid program receiving antipsychotics: remaining barriers to achieving population health prevention goals. JAMA Psychiatry. 2016;73(7):721–30.

    PubMed  Google Scholar 

  69. Stubbs B, Vancampfort D, Hallgren M, Firth J, Veronese N, Solmi M, et al. EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and position statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH). Eur Psychiatry. 2018;54:124–44.

    PubMed  Google Scholar 

  70. Rüther T, Bobes J, De Hert M, Svensson TH, Mann K, Batra A, et al. EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry. 2014;29(2):65–82.

    PubMed  Google Scholar 

  71. Ayerbe L, Forgnone I, Foguet-Boreu Q, González E, Addo J, Ayis S. Disparities in the management of cardiovascular risk factors in patients with psychiatric disorders: a systematic review and meta-analysis. Psychol Med. 2018;48(16):2693–701.

    PubMed  Google Scholar 

  72. Schulze TG, The WPA. Education, science, publication, and research initiative (ESPRI): jumpstarting scientific projects in low- and middle-income countries. World Psychiatry. 2020;19(1):123–4.

    PubMed Central  PubMed  Google Scholar 

  73. Schulze TG. WPA scientific sections: a strengthened backbone for the 2020–2023 triennium. World Psychiatry. 2020;19(3):408–10.

    PubMed Central  PubMed  Google Scholar 

  74. Fiorillo A, Bhui KS, Stein DJ, Okasha T, Ndetei D, Lam LCW, Murthy P, Azeem MW, Javed A. The 2021–2024 work plan of WPA collaborating centres. World Psychiatry. 2021;20(3):457.

    PubMed Central  PubMed  Google Scholar 

  75. Heinze G, Sartorius N, Guizar Sanchez DP, Bernard-Fuentes N, Cawthorpe D, Cimino L, Cohen D, Lecic-Tosevski D, Filipcic I, Lloyd C, Mohan I, Ndetei D, Poyurovsky M, Rabbani G, Starostina E, Yifeng W, EstefaníaLimon L. Integration of mental health comorbidity in medical specialty programs in 20 countries. Int J Psychiatry Med. 2021;56(4):278–93.

    PubMed  Google Scholar 

  76. Ng RMK. WPA educational initiatives: where are we after three years? World Psychiatry. 2020;19(2):257–8.

    PubMed Central  PubMed  Google Scholar 

  77. Kallivayalil RA. Strengthening the functioning of WPA through its secretariat. World Psychiatry. 2020;19(3):407–8.

    PubMed Central  PubMed  Google Scholar 

  78. Kallivayalil RA. The WPA website: newer user-friendly functions. World Psychiatry. 2020;19(1):124. https://doi.org/10.1002/wps.20710.

    Article  PubMed Central  PubMed  Google Scholar 

  79. Kallivayalil RA. WPA Secretariat: keeping pace with changing times! World Psychiatry. 2019;18(2):239. https://doi.org/10.1002/wps.20640.

    Article  PubMed Central  PubMed  Google Scholar 

  80. Herrman H. Implementing the WPA action plan 2017–2020: community orientation for learning, research and practice. World Psychiatry. 2019;18(1):113–4.

    PubMed Central  PubMed  Google Scholar 

  81. Herrman H. Psychiatry, human rights and social development: progress on the WPA action plan 2017–2020. World Psychiatry. 2019;18(3):368–9.

    PubMed Central  PubMed  Google Scholar 

  82. Herrman H. Report on the WPA action plan at the end of the triennium 2017–2020. World Psychiatry. 2020;19(3):404–6.

    PubMed Central  PubMed  Google Scholar 

  83. Herrman H. The practice of psychiatry in health care and sustainable development: progress on the WPA action plan 2017–2020. World Psychiatry. 2020;19(2):256–7.

    PubMed Central  PubMed  Google Scholar 

  84. McEwen BS. The untapped power of allostasis promoted by healthy lifestyles. World Psychiatry. 2020;19(1):57–8.

    PubMed Central  PubMed  Google Scholar 

  85. Groeneweg B. The all-encompassing perspective of the mental health care patient. World Psychiatry. 2019;18(3):296–7.

    PubMed Central  PubMed  Google Scholar 

  86. Slade M, Sweeney A. Rethinking the concept of insight. World Psychiatry. 2020;19(3):389–90.

    PubMed Central  PubMed  Google Scholar 

  87. Galderisi S, De Hert M, Del Prato S, Fagiolini A, Gorwood P, Leucht S, Maggioni AP, Mucci A, Arango C. Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: a Delphi expert consensus study. Eur Psychiatry. 2021;64(1): e7. https://doi.org/10.1192/j.eurpsy.2020.115.

    Article  PubMed Central  PubMed  Google Scholar 

  88. Fiorillo A, Luciano M, Del Vecchio V, Sampogna G, Obradors-Tarragó C, Maj M, ROAMER Consortium. Priorities for mental health research in Europe: a survey among national stakeholders’ associations within the ROAMER project. World Psychiatry. 2013;12(2):165–70. https://doi.org/10.1002/wps.20052.

    Article  PubMed Central  PubMed  Google Scholar 

  89. World Health Organization, WHO. Mental health action plan 2013–2020. WHO Library Cataloguing-in-Publication Data; 2013.

  90. World Health Organization. WHO guidelines on physical activity and sedentary behavior. Geneva: World Health Organization; 2020.

    Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Not funded.

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Campania “L Vanvitelli”, Naples, Italy

    Andrea Fiorillo

  2. Association for the Improvement of Mental Health Programmes, Geneva, Switzerland

    Norman Sartorius

Authors
  1. Andrea Fiorillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norman Sartorius
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AF and NS equally contributed to the manuscript. Both authors read and approved the final manuscript.

Corresponding author

Correspondence to Andrea Fiorillo.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fiorillo, A., Sartorius, N. Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal. Ann Gen Psychiatry 20, 52 (2021). https://doi.org/10.1186/s12991-021-00374-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12991-021-00374-y

Keywords

  • Mortality
  • Physical comorbidity
  • Life expectancy
  • Severe mental disorder
  • Public health

Annals of General Psychiatry

ISSN: 1744-859X